Huddart, RA;
Gabe, R;
Cafferty, FH;
Pollock, P;
White, JD;
Shamash, J;
Cullen, MH;
... National Cancer Research Institute Testis Cancer Clinical Studies Group, .; + view all
(2015)
A randomised phase 2 trial of intensive induction chemotherapy (CBOP/BEP) and standard BEP in poor-prognosis germ cell tumours (MRC TE23, CRUK 05/014, ISRCTN 53643604).
Eur Urol
, 67
(3)
534 - 543.
10.1016/j.eururo.2014.06.034.
![[thumbnail of 1-s2.0-S0302283814006083-main.pdf]](https://discovery.ucl.ac.uk/style/images/fileicons/application_pdf.png) |
PDF
1-s2.0-S0302283814006083-main.pdf Download (1MB) |
Abstract
Standard chemotherapy for poor-prognosis metastatic nonseminoma has remained bleomycin, etoposide, and cisplatin (BEP) for many years; more effective regimens are required.
| Type: | Article |
|---|---|
| Title: | A randomised phase 2 trial of intensive induction chemotherapy (CBOP/BEP) and standard BEP in poor-prognosis germ cell tumours (MRC TE23, CRUK 05/014, ISRCTN 53643604). |
| Location: | Switzerland |
| Open access status: | An open access version is available from UCL Discovery |
| DOI: | 10.1016/j.eururo.2014.06.034 |
| Publisher version: | http://dx.doi.org/10.1016/j.eururo.2014.06.034 |
| Language: | English |
| Additional information: | © 2015 The Authors. Published by Elsevier B.V. on behalf of European Association of Urology. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/). |
| Keywords: | Metastatic germ cell tumour, Poor prognosis, Randomised trial |
| UCL classification: | UCL UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Population Health Sciences > Inst of Clinical Trials and Methodology |
| URI: | https://discovery.ucl.ac.uk/id/eprint/1435634 |
Archive Staff Only
 |
View Item |
